{
  "id": "0843de5a-075c-4a2a-9bed-bfa9fb5d743a",
  "title": "Docusign director Enrique T. Salem sells $915,610 in stock",
  "link": "https://www.investing.com/news/insider-trading-news/docusign-director-enrique-t-salem-sells-915610-in-stock-93CH-3813117",
  "description": "",
  "author": "Investing.com",
  "published": "2025-01-15 00:46:53",
  "source": "https://www.investing.com/rss/news.rss",
  "categories": null,
  "byline": "Investing.com",
  "length": 2079,
  "excerpt": "Docusign director Enrique T. Salem sells $915,610 in stock",
  "siteName": "Investing.com",
  "favicon": "",
  "text": "Salem Enrique T, a director at DocuSign Inc . (NASDAQ:), recently sold 10,000 shares of the company’s common stock. The shares were sold at a weighted average price of $91.561, amounting to a total transaction value of $915,610. This transaction took place on January 10, 2025. In addition to the sale, Enrique T. Salem also exercised options to acquire 10,000 shares of DocuSign common stock at a price of $13.43 per share. This exercise of options, however, did not result in any additional shares being owned post-transaction, as the acquired shares were subsequently sold. Following these transactions, Salem holds 162,265 shares of DocuSign. The sale was executed in multiple transactions at prices ranging from $91.55 to $91.60 per share. In other recent news, Docusign Inc. posted a notable performance in its recent financial quarter, reporting significant gains in revenue, margins, and billings. Several analyst firms including Baird, UBS, and Piper Sandler, have adjusted their outlook on the company, raising their price targets while maintaining neutral ratings. These revisions followed Docusign's successful deployment of its Identity Authentication Management (IAM) product, which is still in the early stages but showing promising initial demand. Meanwhile, Atlassian (NASDAQ:) Corporation reported a strong start to fiscal year 2025, with a 31% surge in cloud revenue, primarily driven by the successful integration of AI capabilities across its cloud platform. Macquarie initiated coverage on Atlassian with a Neutral rating, citing a balance of upside and downside risks influencing the company's outlook. These are recent developments, highlighting the financial health and market position of both Docusign Inc. and Atlassian Corporation. Analyst firms such as Piper Sandler and RBC Capital Markets have provided insights into the companies' performances, emphasizing the importance of revenue growth and the potential of new product offerings. This article was generated with the support of AI and reviewed by an editor. For more information see our T\u0026C.",
  "image": "https://i-invdn-com.investing.com/news/news_six_pile_69x52._800x533_L_1419494215.jpg",
  "html": "\u003cdiv id=\"readability-page-1\" class=\"page\"\u003e\u003cdiv id=\"article\"\u003e\u003cp\u003eSalem Enrique T, a director at \u003cspan itemscope=\"\" itemtype=\"http://schema.org/Corporation\"\u003e\u003cspan itemprop=\"name\"\u003e DocuSign Inc \u003c/span\u003e\u003c/span\u003e. (NASDAQ:), recently sold 10,000 shares of the company’s common stock. The shares were sold at a weighted average price of $91.561, amounting to a total transaction value of $915,610. This transaction took place on January 10, 2025.\u003c/p\u003e\n\u003cp\u003eIn addition to the sale, Enrique T. Salem also exercised options to acquire 10,000 shares of DocuSign common stock at a price of $13.43 per share. This exercise of options, however, did not result in any additional shares being owned post-transaction, as the acquired shares were subsequently sold.\u003c/p\u003e\n\u003cp\u003eFollowing these transactions, Salem holds 162,265 shares of DocuSign. The sale was executed in multiple transactions at prices ranging from $91.55 to $91.60 per share.\u003c/p\u003e\n\u003cp\u003eIn other recent news, Docusign Inc. posted a notable performance in its recent financial quarter, reporting significant gains in revenue, margins, and billings. Several analyst firms including Baird, UBS, and Piper Sandler, have adjusted their outlook on the company, raising their price targets while maintaining neutral ratings. These revisions followed Docusign\u0026#39;s successful deployment of its Identity Authentication Management (IAM) product, which is still in the early stages but showing promising initial demand. \u003c/p\u003e\n\u003cp\u003eMeanwhile, Atlassian (NASDAQ:) Corporation reported a strong start to fiscal year 2025, with a 31% surge in cloud revenue, primarily driven by the successful integration of AI capabilities across its cloud platform. Macquarie initiated coverage on Atlassian with a Neutral rating, citing a balance of upside and downside risks influencing the company\u0026#39;s outlook. \u003c/p\u003e\n\u003cp\u003eThese are recent developments, highlighting the financial health and market position of both Docusign Inc. and Atlassian Corporation. Analyst firms such as Piper Sandler and RBC Capital Markets have provided insights into the companies\u0026#39; performances, emphasizing the importance of revenue growth and the potential of new product offerings.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eThis article was generated with the support of AI and reviewed by an editor. For more information see our T\u0026amp;C.\u003c/em\u003e\u003c/p\u003e\u003c/div\u003e\u003c/div\u003e",
  "readingTime": "3 min read",
  "publishedTime": "2025-01-15T00:46:53Z",
  "modifiedTime": null
}
